Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="cafead, post: 6469195, member: 1"]via Since January, 72 biotech and biopharma companies have hit Wall Street, according to Nasdaq head of healthcare listings Jordan Saxe, together raising $13.2 billion.</p><p><br /></p><p>The latest is Flagship’s Foghorn Therapeutics, which priced its shares last night at $16 apiece, the midpoint of a $15 to $17 range.</p><p><br /></p><p><a href="https://bit.ly/37z17Ba" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://bit.ly/37z17Ba" rel="nofollow">article source</a>[/QUOTE]</p><p><br /></p>
[QUOTE="cafead, post: 6469195, member: 1"]via Since January, 72 biotech and biopharma companies have hit Wall Street, according to Nasdaq head of healthcare listings Jordan Saxe, together raising $13.2 billion. The latest is Flagship’s Foghorn Therapeutics, which priced its shares last night at $16 apiece, the midpoint of a $15 to $17 range. [url="https://bit.ly/37z17Ba"]article source[/url][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing
>